IE00B8KQN827 (IE00B8KQN827)

$133.4B
Market Cap
32.9
P/E Ratio
1.17
Beta
1.28%
Dividend Yield
Piotroski 7/9Altman Z 5.2 SafeBeneish M -2.37 CleanROIC−WACC +1.3%

Quantitative Summary

Deterministic

Financial health metrics are strong: Piotroski 7/9, Altman Z 5.2 (above 3.0 safe zone threshold).

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The capital allocation efficiency demonstrates a modest spread between return on invested capital of 12.8% and the weighted average cost of capital at 11.5%, indicating that value creation is occurring but remains narrow relative to financing costs. Profitability drivers are robust, evidenced by a net margin expansion to 14.9% supported by strong gross margins near 37.6%, while revenue growth continues at a double-digit pace of 10.3%. Financial health metrics further validate this trajectory; the Piotroski F-Score of 7/9 suggests strong fundamental improvement, an Altman Z-Score of 5.2 signals low bankruptcy risk, and a Beneish M-Score of -2.37 points to minimal earnings manipulation concerns.

Valuation multiples reflect high growth expectations rather than current yield compression, with the stock trading at 32.9x forward earnings significantly above typical value benchmarks implied by its capital efficiency profile. The disconnect between the modest ROIC-WACC spread and the premium multiple suggests the market is pricing in substantial future expansion to justify current levels, a premise that must be validated against the DCF fair value estimate of $231. If realized growth fails to meet these implicit assumptions embedded within the 32.9x valuation, the compression gap could widen as earnings power does not fully support the multiple structure.

Risk assessment reveals no immediate distress signals given the high Altman Z-Score and clean Beneish M-Score, yet the narrow margin of safety between returns required to cover capital costs limits downside protection if macro conditions deteriorate. The combination of solid operational fundamentals and elevated pricing creates a scenario where future performance deviations will have amplified impacts on total return, requiring careful monitoring of whether growth rates can sustain the current multiple expansion without further widening the gap between actual ROIC and investor expectations.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →9.5%11.5%13.5%
2%$278$210$165
3%$316$231$179
4%$368$258$195

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=11.5%, terminal growth 3%. Fair value $231 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

7/9
Piotroski F-Score
Strong — high operational efficiency and profitability signals
5.2
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.37
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

37.6%
Gross Margin
14.9%
Net Margin
12.8%
ROIC
11.5%
WACC
ROIC − WACC Spread: +1.3%— Positive spread.
+10.3%
Revenue Growth (YoY)
+7.7%
Earnings Growth (YoY)
3.6B
Free Cash Flow
46%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

Balance Sheet Health

1.12x
Debt / Equity
1.32x
Current Ratio
21.5x
Interest Coverage
1.3x
Net Debt / EBITDA
2.51%
FCF Yield
6.2B
EBITDA

Earnings Surprise History

Q4
✓ Beat
Est: $2.71
Act: $2.72
+0.6%
Q3
✓ Beat
Est: $2.92
Act: $2.95
+0.9%
Q2
✓ Beat
Est: $3.05
Act: $3.07
+0.5%
Q1
✓ Beat
Est: $3.32
Act: $3.33
+0.3%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

21.9
Forward P/E
PEG Ratio
6.86
Price/Book
3M
Avg Volume
$408.45
52W High
$231.85
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$2.1B
Tracked Passive Exposure
7
ETFs Holding IE00B8KQN827
0.21%
Avg Weight in ETFs
$991B
Total ETF AUM

When investors buy or sell ETFs like SCHV or SCHX, the fund manager is mechanically forced to buy or sell IE00B8KQN827 shares regardless of IE00B8KQN827's individual fundamentals. We estimate $2.1B of passive capital is structurally linked to IE00B8KQN827 through 7 tracked ETFs. Index rebalances and ETF creation/redemption cycles can create noticeable volume spikes unrelated to company news.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 7 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in IE00B8KQN827 to visualize passive redemption contagion across ETFs and collateral stocks.

IE00B8KQN827 Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
IE00B8KQN827EpicenterIVVETFITOTETFSCHXETFNVDALow RiskNVDALow RiskAAPLLow RiskAAPLLow RiskMSFTLow Risk
IE00B8KQN827 Price Drop (%)0

If IE00B8KQN827 (IE00B8KQN827) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies NVIDIA Corp. (NVDA) as the most exposed collateral stock, sharing 2 ETFs with IE00B8KQN827. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 7 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

IE00B8KQN827 Ownership Dynamics

Ticker
IE00B8KQN827

Float lock-up computed from 7 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

IE00B8KQN827 Capital Efficiency

How efficiently does IE00B8KQN827 convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$3.6B
EBITDA
$6.2B
FCF Conversion
58%
Reinvestment Rate
42%
58% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
12.8%
ROIC − WACC Spread
1.3%

IE00B8KQN827 converts 58% of its EBITDA into free cash flow, a healthy conversion rate indicating efficient capital management — the business generates substantial cash after reinvestment. The positive ROIC-WACC spread of 1.3% confirms that reinvested capital creates shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Compare IE00B8KQN827 to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.